Journal article
Immunotherapies in Dermatologic Disorders
Abstract
Treatment modalities and therapeutic response experience support the use of immunotherapy in the treatment of many diseases in all fields of medicine. The aim of this article is to conduct and present a review of literature on the use of immunotherapy in the treatment of skin diseases analyzing scientific literature available up to January 2012. Studies that presented evidence-based data were selected. The article discusses how blocking or …
Authors
Fallen RS; Terpstra CR; Lima HC
Journal
, Vol. 96, No. 3, pp. 565–582
Publisher
Elsevier
Publication Date
May 2012
DOI
10.1016/j.mcna.2012.04.004
ISSN
0025-7125
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AdalimumabAlefaceptAlemtuzumabAntibodies, Anti-IdiotypicAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntibodies, Monoclonal, Murine-DerivedBasiliximabDermatologic AgentsEtanerceptHumansImmunoglobulin GImmunoglobulins, IntravenousIpilimumabOmalizumabReceptors, Tumor Necrosis FactorRecombinant Fusion ProteinsRituximabSkin DiseasesTumor Necrosis Factor-alphaUstekinumab